Company entered scientific research agreement with UCSF in June 2021 to study psilocybin effects on various inflammatory conditions Silo Pharma (OTCQB: SILO), recently announced that the University of California San Francisco (“UCSF”) had successfully administered psilocybin to a test group of Parkinson’s disease patients as part of a scientific research agreement (“SRA”) entered with Silo in June, 2021 to “to determine the effects of psilocybin on inflammatory markers of patients who have exhibited Parkinson’s, Bipolar disorder, and chronic back pain. “Successful dosing and collection of blood samples from enrolled patients is an important milestone that demonstrates the progress being made in this study which seeks to examine the effects of psilocybin as an anti-inflammatory agent,” said Eric Weisblum, CEO of Silo Pharma (https://ibn.fm/potDI). “We are encouraged by the progress and look forward to the next cohort of patients receiving therapeutic treatment and sharing the analysis of these markers when data has been analyzed and completed.” Parkinson’s disease is identified by signs that include body tremors, loss of balance, rigid or stiff muscles, slowed movements, speech changes, poor posture, and loss of automatic movements like blinking and swallowing. Scientists believe the disease is caused by nerve cell loss and/or damage in the substantia nigra – a part of the brain responsible for producing dopamine (https://ibn.fm/UGhBz). Dopamine controls and coordinates bodily movements by acting as a messenger between the nervous system and the brain. The connection between dopamine production, Parkinson’s disease, and psilocybin consumption is a growing area of scientific research (https://ibn.fm/65L7b). Psilocybin is a naturally occurring psychedelic prodrug compound produced in over 200 fungi species, and is most potent in the Psilocybe genus that includes P. azurescens, P. semilanceata, and P. cyanescens. Consuming psilocybin in large quantities can produce changes in perception, emotions, and mental cognition through rapid dephosphorylation in the body to psilocin. Accordingly, research suggests that psilocin indirectly increases dopamine concentration in the basal ganglia – a group of neural formations deep in the brain primarily responsible for behaviors, emotions, learning, and executive functions (https://ibn.fm/O7gLS). Scientific research is just beginning to recognize the potential of psychedelics to address the symptoms of numerous chronic diseases. Silo aims to catalyze the movement by fusing traditional therapeutics with psychedelic research to provide innovative treatments for fibromyalgia, post-traumatic stress disorder (“PTSD”), chronic pain, rheumatoid arthritis, Parkinson’s disease, Alzheimer’s disease, and other rare neurological disorders. The company identifies and partners with leading medical universities, providing financial resources that propel cutting-edge research through the clinical stage and into commercialization. For more information, visit the company’s website at www.SiloPharma.com. NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

• The Lightning Network has seen substantial growth over the past few years, doubling capacity year-over-year, and currently offers a capacity of over 4,500 BTC across thousands of channels worldwide
• LQwD currently spans 19 countries, including Japan, England, Canada, France, Australia, Italy, Indonesia, Japan-Osaka, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and US-West
• LQwD’s PaaS offering provides Lightning Network node and channel management, LSP for merchants, and an easy-to-use API for even novice BTC owners

The Lightning Network, a layer 2 payment protocol on the Bitcoin blockchain, set its first capacity record in August 2020, reaching 1,000 BTC. By July 2021, the Lightning Network had doubled its capacity, reaching 2,000 BTC. Continuing on this trend, July 2022 saw double the figure reported the year prior and has now exceeded a capacity of 4,500 BTC across all public nodes, enabling faster transactions atop the Bitcoin blockchain with lower fees and higher security protocols. Nodes and channels on the Lightning Network span the globe, with the top three countries including the United States (2,300 BTC), Germany (355 BTC), and Canada (151 BTC) (https://ibn.fm/kY7Oq). The Lightning Network is scalable, global, open, inclusive, permissionless, and decentralized. Already built, the Network offers the advantage of scaling micropayments on a massive scale and offers a settlement rate of over one million transactions per second versus blockchain with seven transactions per second. The Bitcoin Lightning Network even outperforms Visa, with only 24,000 transactions per second. This, combined with lower fees and higher levels of security per transaction, makes the Lightning Network investment attractive for many crypto-focused businesses. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a financial technology company focused on creating enterprise-grade infrastructure to drive bitcoin adoption, is leveraging its company Bitcoin assets to grow and expand nodes across countries worldwide on the Lightning Network. With a current node count of 19, LQwD’s Lightning Network reach includes Japan, England, Canada, France, Australia, Italy, Indonesia, Japan-Osaka, Bahrain, South Africa, South Korea, Sweden, Singapore, Hong Kong, Brazil, Germany, India, Ireland, and US-West. Using global nodes, LQwD has positioned itself for optimal growth on the network. The company simultaneously released its first node and platform as a service (“PaaS”), https://lqwd.tech/, in November 2021. LQwD’s PaaS offering provides Lightning Network node hosting and channel management, easy-to-use API, and is a Liquidity Service Provider (“LSP”) for merchants on the platform. The company’s total BTC capacity on the Lightning Network exceeds 30 BTC and over 300 channels for micropayment users to execute faster transactions with low fees and more security. LQwD’s current strategy is to offer its PaaS for Lightning Network nodes and payment channels, provide LSP routing and liquidity services, and continue accumulating Bitcoin as a treasury reserve asset for staking and liquidity. LQwD has seen rapid growth with over 56,000 transactions and growing. With a current Lightning Network representation in 19 countries, the company plans to expand to 24 by the end of the current quarter, where it can earn fees in Bitcoin for forwarding payments across the network. With more payment infrastructure going digital, the market outlook for digital payments is expected to reach US $361.30 billion by 2030, growing at a CAGR of 20.5%. Although cryptocurrency plays a minor role in these numbers, the push for payment transparency and enhanced customer experience has played a major role in various developing countries adopting cryptocurrencies over the past year (https://ibn.fm/JjJXf). For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Irregular weather and climate patterns reported to be caused by excess atmospheric carbon
• Net-Zero refers to atmospheric state where carbon added to atmosphere is less than carbon removed, concept emerged at 2015 UN Climate Change Conference
• GeoSolar’s Smart Green™ systems use solar panels and geothermal ground loops to generate power from renewable sources, enables residents and businesses to achieve Net-Zero ahead of government targets
• Company recently qualified by SEC to conduct Regulation A+ capital raise, plans to file for OTCQB listing

Rising temperatures, fierce storms, colder winters, and other irregular weather patterns are prompting citizens, businesses, and governments to take action that balances carbon dioxide (“CO2”) in the atmosphere. Referred to as “Net-Zero”, this ambitious goal aims to achieve carbon neutrality by limiting CO2-releasing activities associated with manufacturing, transportation, agriculture, and energy production. GeoSolar Technologies (“GST”), a Colorado-based climate technology company, empowers residents and businesses to achieve Net-Zero with its Smart Green™ systems that leverage the power of the sun and earth to heat and cool buildings, charge electric vehicles, and run electric appliances. Smart Green™ systems also purify the air to maintain quality control standards while reducing or eliminating carbon emissions and maximizing energy efficiency. Achieving “Net-Zero” refers to the balance achieved when the amount of carbon added to the atmosphere is no more than the amount removed. The concept first emerged at the United Nations Climate Change Conference in 2015, where nearly 200 countries signed a legally binding treaty called the Paris Agreement that aims to limit the impact of greenhouse gas emissions (https://ibn.fm/Cevp9). GeoSolar enables residents and businesses to achieve Net-Zero ahead of government targets by revolutionizing how we generate and use power in our homes and commercial businesses. The company’s patent pending Smart Green™ system taps into the power of the earth and sun through solar panels and geothermal ground loops and disperses that energy to power heating and cooling systems, run appliances, and charge electric vehicles. GST also aims to improve efficiency by tightening the building envelope, and upgrading insulation, windows, and lighting systems. GST systems can be built into new construction or retrofitted to existing buildings in a few weeks, enabling property owners to reduce or eliminate utility bills and cut CO2 emissions by up to 8 tons per year (https://ibn.fm/638Z0). With a successful track record in multiple test buildings across Colorado, the company aims to market Smart Green™ to 120 million homes across the United States. GeoSolar was recently qualified by the U.S. Securities and Exchange Commission to conduct a Regulation A+ capital raise, allowing participants to invest in the company’s patent-pending technology for as little as $300 (https://ibn.fm/ovpkG). For more information on GeoSolar’s Regulation A+ capital raise, please visit https://www.manhattanstreetcapital.com/geosolar-technologies-inc. For more information, visit the company’s website at www.GeoSolarPlus.com. NOTE TO INVESTORS: The latest news and updates relating to GeoSolar Technologies are available in the company’s newsroom at https://ibn.fm/GST

• This is the third U.S. patent granted to QSAM, further strengthening its IP portfolio, which consists of 14 patents among three patent families.
• “CycloSam has potential to be a breakthrough therapy for both primary and secondary forms of bone cancer,” says QSAM CEO.
• Patent covers formulation and preparation of CycloSam in the U.S.

QSAM Biosciences (OTCQB: QSAM) has been awarded a key patent for its exclusive radiopharmaceutical drug candidate, CycloSam(R). Granted by the U.S. Patent & Trademark Office, the patent “protects how CycloSam(R) is formulated and prepared, namely by using a nonradioactive kit that can be delivered and stored local to the administration site and provides for high purity in an efficient, facile and reproducible process at lower costs” (https://ibn.fm/J5Gvz). “This patent issuance marks our third granted patent in the United States and further strengthens our IP estate, consisting of 14 patents among three distinct patent families,” stated QSAM Biosciences cofounder and CEO Douglas R. Baum. “Preparation and delivery of radiopharmaceuticals has historically been a challenge, but we believe the protection we have received for our kit formulation and preparation can provide a marketable advantage for both the manufacturing and supply chain for CycloSam, as well as potentially other drug candidates. We also believe CycloSam has potential to be a breakthrough therapy for both primary and secondary forms of bone cancer.” QSAM, a company focused on developing next-generation targeted therapeutic radiopharmaceuticals for the treatment of cancer and related diseases, reported that the patent “covers both formulation and preparation of CycloSam in the U.S. with DOTMP kit formulations for radioisotope delivery targeting bone tumors, as well the high-dosage use of the radiopharmaceutical to perform bone marrow ablations.” “The scope of this patent is fairly broad in that it not only protects the use of QSAM’s primary radioisotope, Samarium-153 (Sm-153), but also several other radioactive materials used in commercialized radiopharmaceuticals such as Lutetium-177 (Lu-177) and Yttrium-90 (Y-90) in conjunction with the chelating agent DOTMP,” the statement continues. “This patent provides the potential to add additional radiopharmaceuticals to QSAM’s pipeline. The kit itself is designed to provide convenient and reproducible preparation of the drug with better delivery and higher purity for each specific formulation.” The patent is the latest of several noteworthy milestones for QSAM’s CycloSam. The targeted, bone-seeking therapeutic radiopharmaceutical has already shown preliminary safety and efficacy in animal studies as well as in a single-patient, FDA-cleared human trial performed in 2020. CycloSam uses low specific activity Samarium-153 combined with DOTMP, a chelator designed to reduce or eliminate off-target migration and targets sites of high bone turnover. The result is a potential treatment for primary and secondary bone cancers as well as a viable candidate for effectiveness trials in bone marrow ablation and procedures to reduce external beam radiation to bone tumors. For more information, visit the company’s website at www.QSAMBio.com. NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM

• Dr. Liqun Han has been appointed as Cepton’s COO, having led the Company’s product development, commercialization, and operations teams over the past several years
• The announcement marks a momentous year for the Company, with Cepton recently revealing that it had opened an expanded office within the Metro Detroit area to strengthen its engagements with automotive OEMs
• Cepton attended the J.P. Morgan Auto Conference on August 10, 2022, where they hosted a live presentation for potential investors and other interested parties

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, announced that they appointed Dr. Han to the position of Chief Operating Officer (“COO”). Dr. Han previously led Cepton’s product development, commercialization, and operational excellence teams since 2016 as Senior Vice President of Operations, and this promotion will accelerate the Company’s efforts in market commercialization and series production readiness. Prior to Cepton, Dr. Han served as Director of Engineering and Technology at KLA-Tencor where he was responsible for core technology innovation and new product introduction. Dr. Han received a Ph.D. in Applied Physics and a M.S. in Electrical Engineering from Stanford University, with a specialty in solid-state electronics and optics. Dr. Jun Pei, Cepton’s Co-Founder and CEO commented in regards to Dr. Han’s appointment: “As one of Cepton’s founding members and a key contributor to the productization and development of MMT lidars, Dr. Han has demonstrated outstanding leadership in driving operational excellence. Liqun has played a pivotal role in enabling Cepton’s leap from a lidar technology innovator to an OEM-validated provider of lidar solutions in just a few years. As we continue to expand collaboration with leading OEM customers, Tier 1 partners, and manufacturing partners, we look forward to Dr. Han’s continued leadership.” Originally founded in 2016 with a focus towards manufacturing lidars for scalable applications in ADAS (“Advanced Driver Assistance Systems”) and autonomous driving capabilities in mass-market consumer vehicles, Cepton has rapidly consolidated its position as a key player within its sector. The company was awarded a significant ADAS lidar series production award with Koito on the General Motors business. Cepton additionally revealed that it was currently engaged in discussions with the other top-10 largest automotive OEMs in the world, as well as with four new electric vehicle OEMs. In addition, lidar technology has become increasingly important within smart infrastructure given its higher accuracy, 3D imaging capabilities, and versality across a variety of adverse weather and lighting conditions. Lidar also protects user privacy by not generating personally identifiable data making it an ideal solution for high traffic, public areas. In early 2022, Cepton was chosen to enable a lidar-based vehicle detection system in Cape Town, South Africa, with the Company’s technology being utilized to facilitate citywide traffic data collection, analytics, and management. Cepton announced the opening of its expanded corporate office in Metro Detroit (Troy, MI), with the location set to serve as the Company’s automotive hub as it seeks to further its ongoing engagements with leading OEMs. The new facility will reinforce Cepton’s commitment towards automotive safety, enabling Cepton to work closely with domestic OEMs as a trusted lidar technology partner. “I’m incredibly proud that our Silicon Valley company, Cepton, has earned Detroit’s trust,” said Dr. Jun Pei. “As we continue to expand our engagements with the top ten global OEMs, locating our experienced team in Detroit will serve us well. Our expanded footprint will help us reach our goal of making lidar a standard safety feature in the cars of today and the key component in the autonomous vehicles of the future.” Lastly, Dr. Jun Pei and Hull Xu, Cepton’s CFO, recently hosted a live presentation at the J.P. Morgan Auto Conference in New York for potential investors and other interested parties. For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

• Lexaria Bioscience, a global innovator in drug delivery platforms, recently announced partnerships with Premier Wellness Science Co., BevNology, AnodGen Bioceuticals, and Valcon Medical A/S
• According to coverage by Zacks Small-Cap Research, who value Lexaria at $15 per share, the most impactful of these partnerships is with Premier because the company is expected to start paying license fees in early September
• In a June 7 Fireside Chat, Lexaria Chair and CEO Chris Bunka disclosed that the company is capitalizing on partnerships with “national players in different areas of the world” to improve its “revenue picture” and offset its cash burn
• In the longer term, the company is targeting milestone payments from large national and international consumer companies and pharmaceutical organizations

In a June 7 Fireside Chat hosted by John D. Vandermosten, CFA, of Zacks Small-Cap Research (“SCR”), Lexaria Bioscience (NASDAQ: LEXX) Chair and CEO Chris Bunka expressed hope that the then-ongoing negotiations with “national players in different areas of the world” would yield contracts that would significantly improve its revenue (https://ibn.fm/qhlo1). The negotiations led to separate announcements that form the basis of Zacks SCR’s latest coverage of the company, who value Lexaria at $15 per share (https://ibn.fm/OvOaJ). “Lexaria experienced a substantial amount of activity on both the drug development front and in closing agreements with partners since the end of the fiscal second quarter,” Zacks notes in its coverage (https://ibn.fm/sGXzP). “The company announced four material partnerships in June that will provide a variety of upfront, milestone, and royalty opportunities over the next quarters and years to come.” Lexaria announced partnerships with Premier Wellness Science Co., BevNology, AnodGen Bioceuticals, and Valcon Medical A/S. The most impactful of these, the Zacks report notes, is with Premier because the company is expected to start paying license fees and launch its products using Lexaria’s patented DehydraTECH(TM) technology in Japan. The agreements with AnodGen and Valcon, on the other hand, are longer-term in nature. As detailed in a June 3 press release, Lexaria granted an exclusive license to Premier authorizing the latter’s use of its DehydraTECH technology in various cannabidiol (“CBD”) products that may be in oral liquid or non-liquid form. In addition, per the terms of the agreement, DehydraTECH may also be used in topical, hair-care, lip-care, and cosmetics segments (https://ibn.fm/3cnkt). “The arrangement includes minimum payments of $4.5 million to be paid over the first five years of the deal to maintain exclusivity,” Zacks SCR explains. “The license payments will start from a small base and grow as the arrangement moves into its final years. First payments will be made to Lexaria on September 1. Royalty percentages were not disclosed, nor were Premier sales forecasts; however, the press release noted that under the worst-case sales projection by Premier, Lexaria could receive annual royalties of over $5 million.” The license and royalty payments are part of a short-to-medium-term revenue-generation strategy, with the company eventually targeting milestone payments from companies primarily in the pharmaceutical sector as part of its longer-term strategy. And to make its DehydraTECH technology more attractive for large national and international consumer companies and pharmaceutical organizations, Lexaria has invested a lot of time and resources in validating its R&D programs (https://ibn.fm/ZulHA). “If people are unaware, for small pharma companies like ourselves, our most likely path to commercial success comes through milestone payments with pharma where you elevate, through Phase I, into Phase II, and so on, a drug or delivery system. And usually, those payments are quite large, usually, tens of millions and sometimes hundreds of millions of dollars, [and can cover our R&D programs]. And I want to assure our shareholders that we want to be able to cover these programs without issuing any more equity,” Chris Bunka said during the Fireside Chat. In the interim, Lexaria has maintained tremendous fiscal prudency while supporting its R&D programs. According to Bunka, the company’s spending is within its projected budgetary expectations, having raised $15 million in 2021. Currently, the company has between $7-8 million in its bank accounts, which it projects will support its operations through the third quarter of 2023. But by partnering with the companies such as Premier, Lexaria is making strides to improve its “revenue picture” and offset “more of our cash burn.” Lexaria is a global innovator in drug delivery platforms that has developed DehydraTECH, shown to improve the bioavailability, speed of onset, and brain absorption of pharmaceuticals and therapeutics. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• CubCrafters, producer of best-in-class Backcountry Aircraft, recently reported it would welcome public investment for the first time in its 42-year history
• 48 hours after making the announcement, the company indicated that the reservations for its offering (via a Regulation A exemption) had crossed the $5 million mark, representing over 10% of the $50 million goal
• According to the company, the money raised through this public offering is set to go toward increasing production speed, improving service and support for owners of its aircraft, and accelerating innovation
• CubCrafters is eagerly anticipating qualification of the offering by the SEC, which will allow the conversion of the reservations into actual investments

Becoming a publicly-traded company was a long-standing vision of the company Founder, Jim Richmond.  Because of this, Cub Crafters (typically styled CubCrafters), a Yakima, Washington-based OEM designer and producer of backcountry aircraft has now commenced plans to materialize his vision, and is currently allowing potential investors to reserve shares in an upcoming public offering. The news that outside investment would be allowed for the first time in the 42 year history of the company excited potential investors, who reserved more than 1,000,000 shares of stock, worth more than $5 million (https://ibn.fm/QZ97i), in just the first 48 hours after the reservation period opened. Given the company’s goal is to raise $50 million for an expansion of its operations, the company has opted to file for a Regulation A exemption from the 1933 Securities and Exchange Act (https://ibn.fm/B2JGF). If approved by the Securities and Exchange Commission (“SEC”), this exemption will allow customers of the company, its fans, aviation enthusiasts, and even the general public to purchase shares of preferred stock in the company at the offering price of just $5 per share. “Regulation A is uniquely suited to CubCrafters because the company appeals to a large audience of pilots and aviation enthusiasts; it has a large and loyal customer base,” explained Rod Turner, CEO of Manhattan Street Capital, an online fundraising platform advising CubCrafters on the Reg A offering, in an earlier news release (https://ibn.fm/5UvyU). “Providing fans and customers with easy access to become owners of the company makes great use of the online investing process that can be used in this type of public offering.” According to Rod, the reservations, which account for more than 10% of the company’s goal, demonstrate investors’ remarkable enthusiasm and embody the reputation CubCrafters has earned over its 42 years in business. Founded in 1980 in the rural Washington State community of Yakima as a company that repaired and restored the historic Piper Cub light aircraft, CubCrafters has grown into a Federal Aviation Administration (“FAA”) certificated OEM of Part 23 Certified, Experimental, and Light Sport (“LSA”) Backcountry Aircraft, currently offering over seven unique models. The company introduced its first ‘new’ aircraft, the Piper/CubCrafters PA18, in 1999, built under the Federal Aviation Administration (“FAA”)’s Spare & Surplus Rule. Later, in 2004, the company introduced the Piper-Super-Cub-inspired Top Cub, which featured a modernized design that met the Part 23 certification (https://ibn.fm/IdisS). In 2006, CubCrafters introduced its first LSA, the Sport Cub, and in 2009, it updated this aircraft’s engine to make it lightweight but capable of outputting 180 horsepower. The company renamed the Sport Cub to Carbon Cub SS in 2010 and now offers a kit version of the Carbon Cub SS under the trade name Carbon Cub EX. CubCrafters’ focus on innovation and independence became more apparent in 2016 when it introduced the XCub following close to six years of development. Built organically using the company’s resources and not involving any loans, venture capital, or customer deposits, the XCub has a wholly original fuselage design and meets the latest FAA Part 23 certification standards. Since its inception, CubCrafters has manufactured a fleet of about 1,500 new aircraft and restored or rebuilt scores of others. Furthering its storied reputation, the company indicates that the current order backlog exceeds two years, with efforts ongoing to increase production. So, with an eye on, among other targets, reducing this waiting period, CubCrafters is welcoming new public investment. “Reservations for over 10% of our $50 million goal in only two days is just amazing. This level of interest from the aviation community and the general public tells us that they see real value in our company and want to help it grow,” commented CubCrafters VP of Sales Brad Damm. “Backcountry aviation is increasing in popularity, and the demand for our aircraft continues to grow. We want to build airplanes faster to reduce the amount of time a customer has to wait to get a new airplane, we want to improve service and support for our owners, and we want to accelerate our focus on new innovation. Our goal is to exceed our customers’ expectations.” CubCrafters is offering its preferred stock for a price of $5 per share, with a minimum investment of only $400. The reservations are non-binding and can be made through the link: www.ManhattanStreetCapital.com/CubCrafters. For more information, visit the company’s website at www.CubCrafters.com. NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

• Global financial advisory firm Morgan Stanley, through its Real Estate Investing (“MSREI”) business, has identified the growing trend toward improving corporate building facilities’ utilities usage as a benefit to the climate and to real estate investors
• Recent legislation has generated excitement among climate change policy proponents because of its moves to fund greenhouse gas reduction activities
• Correlate Infrastructure Partners, a Louisiana-based driver of energy use optimization, anticipates seeing its growth strategies benefit from the legislative package as it works to promote improvements to HVAC, mechanical, electrical, and plumbing processes, key elements for cost-effective improvement of energy efficiency
• CIPI provides analysis and education to corporate clients that help them to recognize their greenhouse gas emissions and how to improve them, benefitting their financial bottom lines in the process

A legislative proposal in Congress designed to reduce inflation is generating excitement among proponents of climate-friendly action because of its generous provisions for benefiting those who try to reduce carbon emissions pollution (https://ibn.fm/Qp3Js). Correlate Infrastructure Partners (OTCQB: CIPI), a company focused on reducing climate change through improving the ways corporate buildings use energy, applauded the legislation for its funding initiatives that have the potential to help reduce greenhouse gas emissions by 40 percent by 2030 (https://ibn.fm/Tj1HG). CEO Todd Michaels stated in the news release that the legislation may benefit Correlate Infrastructure’s growth initiatives through solar energy tax credits and establishing greater flexibility for companies to monetize the tax credits, adding “These two key proposals have the potential to accelerate Correlate’s growth, support our ability to own and operate nationwide solar and storage assets, and contribute to strengthening the economy through clean energy project deployment.” Global financial services powerhouse Morgan Stanley issued an investment policy paper through its Real Estate Investing (“MSREI”) business a few years ago that highlighted the importance of facilities’ energy efficiency and performance optimization trends as a vehicle driving value for real estate investors. “Overall, the real estate investment team estimates that a typical office building that integrates sustainable practices could help reduce building expenses by 3 to 30 percent, creating $3.5 billion to $34.9 billion of asset value in the top 10 U.S. markets in the process,” the investor briefing states (https://ibn.fm/guBLr). “Through reduced utility costs alone, MSREI investment managers estimate that applying existing technology could generate annual savings in office buildings ranging from $32 million in Philadelphia to $239 million in New York City, thus creating $489 million and $4.8 billion of asset value, respectively.” Morgan Stanley’s research identifies corporate buildings as consumers of about 40 percent of energy and 25 percent of water resources, creating a source for about 33 percent of the world’s greenhouse gases fueling climate change, and also reducing valuable resources in areas where supplies are already at critical levels. Correlate Infrastructure Partners mission is to improve corporate clients’ environmental governance (“ESG”) strategies by measuring and analyzing their current utilities’ use, educating clients on their potential improvements and the financial savings available to them, and helping them to implement strategic changes. As clients provide CIPI with records of their utility bills over the past year and opt in to the company’s advisement, they kick off a pathway to greater environmental responsibility and possible cost reductions through improvements to HVAC, mechanical, electrical and plumbing processes, the addition of solar upgrades, water optimization and antimicrobial airflow, the strategic procurement of energy sources, vehicle electrification and master controls that provide intelligent oversight of any retrofits. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• Golden Matrix Group Inc revealed that revenues for the third fiscal quarter ending July 21, 2022, exceeded $9 million
• The record top-line result marks a significant, 177% increase on a year-over-year basis
• Management attributed the strong performance to continued growth within the company’s B2B and B2C segments, noting that there were approximately 635 operators and 6.5mn registered users across its platforms at the present juncture

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, set a record for the third fiscal quarter ended July 21, 2022, reporting revenues exceeding $9 million – equivalent to an estimated 177 percent increase relative to the $3.25 million registered in the equivalent period a year ago. Moreover, the company’s strong third quarter results will likely extend Golden Matrix Group’s robust recent performance, a trend which saw the company report its 15^th consecutive quarter of profitability in 2QFY2022. While detailed quarterly results are set to be released following the submission of the company’s Form 10-Q, which is set to be filed with the Securities and Exchange Commission in early September 2022, Golden Matrix Group’s strong top-line performance is likely to stem from continued development and expansion of the firm’s B2B and B2C business lines. Prior to fiscal 2022, Golden Matrix Group’s revenues were largely derived from licensing fees received from gaming operators located within the Asia Pacific region, who partook of the company’s GM-X turnkey solution, a complete software package designed to support online gaming businesses. The white-labelled service provided third party gaming platforms with access to GMGI’s expansive portfolio of over 10,000 games, ranging from online slots, casino table games, live operator games, and more drawn from Golden Matrix Group’s partnership with upwards of 25 providers. The historic reliance on the B2B business line was dramatically revamped following the company’s acquisition of an 80 percent controlling interest in UK-based RKings Competitions Ltd in November 2021, a purchase that allowed GMGI to significantly boost their B2C business vertical. In addition to contributing approximately $5.1 million of the group’s total revenues for the second quarter of the 2022 fiscal year, RKings’s unique competitions have also resulted in GMGI acquiring thousands of new players a quarter at relatively low cost – a crucial factor towards growing out their addressable consumer universe going forward. Golden Matrix CEO, Brian Goodman commented following the release of the third quarter result highlights, “We are excited by meaningful progress and growth in both our B2B and B2C divisions. The company has now recorded its first $9 million quarter, which is even more impressive when considering the impact of global economic headwinds and an unfavorable exchange rate throughout the quarter.” Mr. Goodman further elaborated upon the ongoing expansion of the company’s B2B and B2C verticals in recent months, noting that there were approximately 635 operators and about 6.5 million registered users across all GMGI’s traditional B2B gaming platforms at present. Moreover, he noted that RKings’ B2C competitions had engaged more than 46,000 new registered users during the most recent quarter. Lastly, Mr. Goodman also revealed that the company’s gaming permit in Mexico had recently been approved, a key milestone set to permit GMGI to continue its recent move towards the diversification of its geographic revenue base. “We are now finalizing required merchant services to operate there and expect to go live during the current quarter,” he remarked. For more information, visit the company’s website at www.GoldenMatrix.com. NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

• FingerMotion has evolved with the developing need for advanced telecommunications products and services, from SMS and MMS services, to big data insights, and RCS, starting with a focus on China
• Its latest addition, the device protection program, looks to tap into the $10.6 billion Chinese market, with over 1.2 billion mobile phone users, most of whom do not have access to a device protection plan
• The mobile phone insurance market is expected to hit $53.16 billion globally by 2028, and FingerMotion is targeting this growth, with eyes on expanding into other markets over time

Since it was founded in 2016, FingerMotion (NASDAQ: FNGR), a leader in mobile payment and recharge platform solutions in China, has been no stranger to reinventing itself and adjusting to changing customer preferences. Today, its goal remains to serve over a billion users in China and expand its model to other regional markets. However, its management understands that this will only be achieved by the company adjusting and improving its operations to address the changing market environment and evolving customer needs. With every passing year, FingerMotion has gained experience in the market and from interacting with key partners in various sectors. It continues to leverage all this to improve its services and the value offered to consumers. This has allowed it to grow its list of offerings into four main areas: telecommunications products and services, SMS and MMS services, big data insights, and Rich Communication Services (“RCS”). Its latest addition, the device protection program, stems from FingerMotion recognizing a vast untapped market in China, valued at approximately $10.6 billion annually. It seeks to target the over 1.2 billion mobile phone users in the country, most do not have access to a device protection plan (https://ibn.fm/76zRi). It is a bold move by the company, and its management is confident that it will pay off significantly over the next 6-12 months as more potential customers shift from 3G and 4G to 5G. “Now with the massive onset of 5G phones, there’s a really large market in China that’s looking to change up their phones for, let’s say, 3G and 4G phones to 5G. So, as (consumers) go and get new phones, the cost of this AppleCare(-similar product) is built in. So that revenue is already there,” noted Martin Shen, FingerMotion’s Chief Executive Officer (“CEO”), while appearing in an interview with Proactive, an investor media outlet (https://ibn.fm/HOdFC). Globally, the mobile phone insurance market is projected to hit $53.16 billion by 2028, up from $27.29 billion in 2021. This will represent a CAGR of 10.4%, mainly attributed to the surge in uptake of high-quality smartphones and increasing cases of accidental damage, phone theft, and gadget failure (https://ibn.fm/jJmAW). FingerMotion looks to tap into this growth, starting with the Chinese market as it hopes to expand to other regions as time progresses. Through this diversification and overall growth of its product line, FingerMotion is confident that it can continue to build on the 37% growth experienced this year over the previous financial year. “I think our revenue right now is really just the top of the iceberg, just building on the top-up and SMS (services),” noted Mr. Shen. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR